These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 19408276

  • 1. A retention-time-shift-tolerant background subtraction and noise reduction algorithm (BgS-NoRA) for extraction of drug metabolites in liquid chromatography/mass spectrometry data from biological matrices.
    Zhu P, Ding W, Tong W, Ghosal A, Alton K, Chowdhury S.
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1563-72. PubMed ID: 19408276
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism.
    Picard N, Dridi D, Sauvage FL, Boughattas NA, Marquet P.
    J Sep Sci; 2009 Jul; 32(13):2209-17. PubMed ID: 19569100
    [Abstract] [Full Text] [Related]

  • 5. Algorithm for thorough background subtraction of high-resolution LC/MS data: application to obtain clean product ion spectra from nonselective collision-induced dissociation experiments.
    Zhang H, Grubb M, Wu W, Josephs J, Humphreys WG.
    Anal Chem; 2009 Apr 01; 81(7):2695-700. PubMed ID: 19254033
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M, Bessire A, Song W, Huntington C, Groeber E.
    Rapid Commun Mass Spectrom; 2010 Jul 15; 24(13):1902-10. PubMed ID: 20533320
    [Abstract] [Full Text] [Related]

  • 9. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.
    Zhu M, Ma L, Zhang D, Ray K, Zhao W, Humphreys WG, Skiles G, Sanders M, Zhang H.
    Drug Metab Dispos; 2006 Oct 15; 34(10):1722-33. PubMed ID: 16815965
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
    Kiffe M, Graf D, Trunzer M.
    Rapid Commun Mass Spectrom; 2007 Oct 15; 21(6):961-70. PubMed ID: 17299833
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B, Singh S.
    J Pharm Biomed Anal; 2009 Oct 15; 50(3):475-90. PubMed ID: 19535209
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.